期刊文献+

重组TACE前肽对自身TACE活性的抑制作用 被引量:1

Inhibition of the recombinant TACE pro-domain to TACE
原文传递
导出
摘要 目的以脂多糖(LPS)刺激人单核细胞型淋巴瘤细胞株THP-1为模型,观察重组肿瘤坏死因子α转换酶(TACE)前肽结构域对催化TACE结构域的自身抑制作用,为人工干预炎症过程提供依据和手段。方法首先利用DNA重组技术分别构造含前肽结构域和催化结构域的重组载体:用PCR方法扩增出TACE的胞外结构域(T1300)和前肽结构域(T591),并克隆至载体pET-28a(+)中,转化至大肠杆菌BL21,经IPTG诱导表达出带有His-tag的目的蛋白,两者均为包涵体,变性复活后经Ni^2+ -NTA亲和层析柱对表达的重组蛋白进行纯化。对纯化后的蛋白进行Western blot分析。LPS分时相刺激THP-1细胞后,用细胞学技术观察纯化的T591在蛋白质水平上对TACE的表达和活性的影响。结果TACE重组前肽蛋白能显著抑制TACE的活性,减少分泌型TNF-α(sTNF-α)分泌,抑制率达57%。结论TACE重组前肽抑制了TACE的活性,降低了sTNF-α的分泌,为抗炎药物的设计和改造提供了新的依据和方法。 Objective To study the effect of tumor necrosis factor-α (TNF-α) converting enzyme (TACE) inhibitors on TNF-α secretion and to develop an approach to interfere inflammation processes. Methods The cDNA coded for full-length ectodomain (T1300) and pro-domain(T591) of TACE was amplified by PCR. The expression plasmid was constructed and transformed into E. coli BL21 ( DE3 ). After Ni2 + -NTA resin affinity chromatography, the recombinant T591 protein was obtained and assayed by Western blot. The experiment in vitro was carried out on THP-1 cell lines stimulated by LPS. The inhibition of recombinant protein to TACE was detected by ELISA and immunohistochemical technique. Results The recombinant pro-domain protein inhibited 57% of TNF-α secretion and mediated the accumulation of TNF-α on the surface of THP-1 cell. Conclusion The recombinant pro-domain protein is an effective antagonist of TACE and inhibite the secretary TNF-α release, which indicates that TACE is a novel target for inflammation therapy.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2008年第1期69-74,共6页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助项目(30371309)
关键词 肿瘤坏死因子Α 肿瘤坏死因子α转换酶 前肽结构域 抑制剂 Tumor necrosis factor-α (TNF-α) TNF-α converting enzyme Pro-domain Inhibitor
  • 相关文献

参考文献11

  • 1Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumor-necrosis factor-alpha from cells. Nature, 1997, 385(6618) : 729-733.
  • 2Moss ML, Jin SL, Milla ME, et al. Cloning of a disintegrin metalloprotease that processes tumor-necrosis factor-alpha. Nature, 1997, 385 (6618 ) : 733-736.
  • 3Lichtenthaler SF, Haass C. Amyloid at the cutting edge: activation of alpha-secretase prevents amyloidogenesis in an Alzheimer disease mouse model. J Clin Invest, 2004, 113 (10): 1384- 1387.
  • 4Anders A, Gilbert S, Garten W, et al. Regulation of the alphasecretase ADAM10 by its prodomain and proprotein convertases. FASEB J, 2001, 15(10) : 1837-1839.
  • 5Hansen HP, Dietrich S, Kisseleva T, et al. CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme. J Immunol, 2000, 165(12) : 6703-6709.
  • 6Amin AR. Regulation of tumor necrosis factor-alpha and tumor necrosis factor converting enzyme in human osteoarthritis. Osecoarhritis Cartialge, 1999, 7(4) : 392-394.
  • 7朱孔黎,杨渝珍,韩玲,王震,丁廷波.三类TACE抑制剂的作用机理探讨[J].中国免疫学杂志,2003,19(11):752-756. 被引量:6
  • 8Loechel F, Gilpin BJ, Engvall E, et al. Human ADAM 12 (meltrin alpha) is an active metalloprotease. J Biol Chem, 1998, 273 (27) : 16993-16997.
  • 9Stour N, Lebel A, McMabon S, et al. TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity. FEBS Lett, 2003, 554 (3) : 275-283.
  • 10Howard L, Maciewicz RA, Blobel CP. Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28. Biochem J, 2000, 348(Pt 1) : 21-27.

二级参考文献9

  • 1吴朝栋,李鸣真,张艳萍,林宝英,罗明,徐丽君.中药热毒清对内毒素DIC家兔血浆肿瘤坏死因子α、白细胞介素6水平影响的研究[J].中国中西医结合杂志,1995,15(6):356-358. 被引量:31
  • 2Moss L. Cloning of a disintegrin metalloproteinase that processes precursor tumor neerosis factor-α[J]. Nature, 1997 ;385:373-376.
  • 3Fald H D, Loppnow H. Agonists and antagonsists for LPS-induced cytokines[J]. Immunology, 1993; 187:303-316.
  • 4Amin A R. Regulation of tumor necrosis factor-alpha and tumor necrosis factor converting enzyme in human osteoarthritis[J]. Osecoarthritis Cartialge, 1999;7(4) :392-394.
  • 5Buxbaum J D,Liu K N,Luo Y et al. Evidence that tumor necrosis factor alpha converting enzyme is involoved in regulated alpha secretase cleavage of the Alzheimer amyloid protein precursor[J]. J Biol Chem, 1998;273(43) :277765-277767.
  • 6Hansen H P, Dietrich S, Kisseleva T et al. CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme [ J ]. J Immunol, 2000; 165(12) :6703-6709.
  • 7Black R A,Rauch C T, Kozlosky C J et al. A metalloproteinasc disintegrin that releases tumour-necrosis factor-alpha from cells [J]. Nature,1997;385(6618) :729-733.
  • 8Flick D A,Gilford G E.Comparation of in vitro cell toxic assayes for tumor necrosis factor-α[J]. J Immunol Methods, 1984;68(1 - 2) : 167-175.
  • 9王鼎,许家喜.肿瘤坏死因子及其抑制剂[J].生命的化学,1999,19(4):189-191. 被引量:7

共引文献5

同被引文献35

  • 1Black R A, Rauch C T, Kozlosky C Jet al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [ J ]. Nature, 1997 ; 385(6618) :729-733.
  • 2Moss M L, Jin S L, Milla M E et al. Cloning of a disintegrin metallopro- teinase that processes precursor tumour-necmsis factor-alpha [ J ]. Nature,.1997; 385 (6618) : 733-736.
  • 3Srour N, Lebel A, McMahon Set al. TACE/ADAM-17 maturation and ac- tivation of sheddase activity require proprotein convertase activity [ J ]. FEBS Lett, 2003 ; 554 (3) : 275-283.
  • 4Reddy P, Slack J L, Davis R et al. Functional analysis of the domain structure of tumor necrosis factor-alpha conveing enzyme [ J ]. J Biol Chem,2000;275(19) :14608-14614.
  • 5Sisto M,Lisi S,Lofrumento D D et al. TNF-a blocker drugs modulate hu- man TNF-a-converting enzyme pro-domain shedding induced by autoanti- bodies[ J]. Immunobiology, 2010; 215 ( 11 ) : 874-883.
  • 6Peiretti F, Cananlt M, Deprez-Beauclair Pet al. IntracellMar maturation and transport of tumor necrosis factor alpha converting enzyme [ J ]. Exp Cell Res, 2003 ; 285 ( 2 ) : 278-285.
  • 7Zmg Q, Thomas S M,Lni V Wet al. Phosphorylation of TNF-alpha con- verting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation[J]. Proc Natl Acad Sci USA, 2006; 103 (18) : 6901-6906.
  • 8Yin J, Yu F S. ERK1V2 mediate wounding-and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding[ J]. Invest Ophthalmol Vis Sci, 2009; 50( 1 ) : 132-139.
  • 9Canault M, Tellier E, Bonardo B et al. FHL2 interacts with both ADAM- 17 and the cyteskeleton and regulates ADAM-17 localization and activity [J] .J Cell Physiol,2006;208(2):363-372.
  • 10Nishi E, Hiraoka Y, Yoshida K et al. Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme[ J]. J Biol Chem,2006;281 (41) :31164-31172.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部